The triple transgenic 3×Tg-AD mice behaviorally exhibit moderate to severe behavioral impairment of AD, downregulation of FTO expression, formation of Aβ plaques and NETs, as well as gliosis, synaptic damage, and neuronal loss in neuropathology (Wang et al., 2021). This evidence concerns the gene FTO and Alzheimer disease.